Aiko Yamaguchi, Yasuaki Anami, Summer Y Y Ha, Travis J Roeder, Wei Xiong, Jangsoon Lee, Naoto T Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Antibody-drug conjugates (ADCs) hold great therapeutic promise for cancer indications; however, treating tumors with intratumor heterogeneity remains challenging. We hypothesized that ADCs that can simultaneously target two different cancer antigens could address this issue. Here, we report controlled production and evaluation of bispecific ADCs chemically functionalized with tumor-targeting small molecules. Enzyme-mediated conjugation of bi-functional branched linkers and following sequential orthogonal click reactions with payload and tumor targeting modules (folic acid or RGD peptide) afforded homogeneous bispecific ADCs with defined ligand/drug-to-antibody ratios ranging from 4 + 4 to 16 + 4 (ligand/payload)...
January 9, 2021: Bioorganic & Medicinal Chemistry
Megumi Matsumoto, Hiroshi Yano, Ryota Otsubo, Aya Tanaka, Takeshi Nagayasu
INTRODUCTION: Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein present a case of metastatic breast cancer in a patient undergoing HD. PRESENTATION OF CASE: A 58-year-old Japanese woman with breast cancer undergoing HD underwent total mastectomy of the left breast and left axillary dissection. Histopathological examination revealed invasive ductal carcinoma, and the diagnosis was pT2N3cM0 Stage ⅢC...
January 15, 2021: International Journal of Surgery Case Reports
Amir Nazari, Beatriz G Lopez-Valcarcel, Safa Najafi
OBJECTIVE: Some hormonal and targeted treatment options are available in the first line of metastatic HR+ & HER2- breast cancer. This study aimed to quantify the preferences of Iranian breast cancer patients regarding the levels of attributes of hypothetical treatment options. METHODS: The discrete choice experiment included 16 orthogonally designed scenarios. A novel method (named "the World Cup") was used to offer the scenarios to the respondents...
January 19, 2021: Value in Health Regional Issues
Bernardine M Pinto, Shira Dunsiger
BACKGROUND: Thoughtful approaches to study recruitment are a critical step in designing and implementing randomized controlled trials. Delays and challenges in recruitment can be costly and can result in smaller than proposed sample sizes which have downstream effects, such as underpowered studies. PURPOSE: The current study evaluated recruitment methods (e.g., targeted mailings, brochures/flyers, social media) and their relationship to eligibility, randomization, participant characteristics and retention at end of a randomized controlled trial of physical activity adoption and maintenance among breast cancer survivors...
January 19, 2021: Contemporary Clinical Trials
Suad A K Shamis, Donald C McMillan, Joanne Edwards
No abstract text is available yet for this article.
January 19, 2021: Critical Reviews in Oncology/hematology
Paolo Tarantino, Sara Gandini, Dario Trapani, Carmen Criscitiello, Giuseppe Curigliano
IMPORTANCE: Several randomized trials of neoadjuvant chemo-immunotherapy in early triple negative breast cancer (TNBC) have been recently reported, showing conflicting results. METHODS: We systematically searched PubMed, Cochrane CENTRAL, Embase and key oncological meetings for trials of neoadjuvant chemo-immunotherapy in TNBC. The primary endpoint was pCR, with sub-analyses based on PD-L1 expression and risk of relapse RESULTS: Five randomized trials enrolling 1496 TNBC patients were included...
January 19, 2021: Critical Reviews in Oncology/hematology
OPhir Nave, Miriam Elbaz
We here propose a new method of combining a mathematical model that describes a chemotherapy treatment for breast cancer with a machine-learning (ML) algorithm to increase performance in predicting tumor size using a five-step procedure. The first step involves modeling the chemotherapy treatment protocol using an analytical function. In the second step, the ML algorithm is trained to predict the tumor size based on clinico-pathological data and data obtained from magnetic resonance imaging results at different time points of treatment...
January 19, 2021: Bio Systems
Xiaobo Li, Minfeng Chen, Weijin Lu, Jun Tang, Lijuan Deng, Qing Wen, Maohua Huang, Rong Deng, Geni Ye, Wencai Ye, Dongmei Zhang
Tumor metastasis is the main cause of death in patients with triple-negative breast cancer (TNBC). Bone marrow-derived mesenchymal stem cells (BM-MSCs) have tropism towards tumor tissues, and can be converted into tumor-associated mesenchymal stromal cells (TA-MSCs) to facilitate TNBC metastasis through interactions with tumor-associated macrophages (TAMs). However, the underlying molecular mechanisms are complex and unclear, and effective strategies to suppress tumor metastasis via eliminating TA-MSCs are still lacking...
January 19, 2021: Cancer Letters
Athanasios A Panagiotopoulos, Chara Polioudaki, Sotirios G Ntallis, Dimitris Dellis, George Notas, Christos A Panagiotidis, Panayiotis A Theodoropoulos, Elias Castanas, Marilena Kampa
BACKGROUND: Nuclear translocation of large proteins is mediated through specific protein carriers, collectively named karyopherins (importins, exportins and adaptor proteins). Cargo proteins are recognized by importins through specific motifs, known as nuclear localization signals (NLS). However, only the NLS recognized by importin α and transportin (M9 NLS) have been identified so far METHODS: An unsupervised in silico approach was used, followed by experimental validation. RESULTS: We identified the sequence EKRKI(E/R)(K/L/R/S/T) as an NLS signal for importin 7 recognition...
January 19, 2021: Biochimica et Biophysica Acta. General Subjects
Abdulaziz S Alshabibi, Moayyad E Suleiman, Kriscia A Tapia, Robert Heard, Patrick C Brennan
OBJECTIVES: To examine whether radiologists' mammogram reading performance varies according to how long they have been awake and the number of hours they slept the night before a reading session. METHODS: Retrospective data were retrieved from the BreastScreen Reader Assessment Strategy database. Malignancy-enriched mammographic readings were performed by 133 radiologists. Information on their hours awake and hours slept was collected. Analysis of covariance was performed to determine whether these two variables influenced radiologists' sensitivity, specificity, lesion sensitivity, receiver operating characteristic (ROC) curve, and jackknife alternative free-response ROC...
January 19, 2021: Journal of the American College of Radiology: JACR
Yannick Audet-Delage, Julie St-Pierre
In this issue of Molecular Cell, Rinaldi et al. (2021) reveal how nutrient availability in the metastatic niche of breast cancer cells shapes their growth signaling, highlighting potential avenues for therapeutic interventions.
January 21, 2021: Molecular Cell
Nuria Vives, Albert Farre, Gemma Ibáñez-Sanz, Carmen Vidal, Gemma Binefa, Núria Milà, Maria Jose Pérez-Lacasta, Noemie Travier, Llucia Benito, Josep Alfons Espinàs, Guillermo Bagaria, Montse Garcia
BACKGROUND: Short message service (SMS) based interventions are widely used in healthcare and have shown promising results to improve cancer screening programs. However, more research is still needed to implement SMS in the screening process. We present a study protocol to assess the impact on health and economics of three targeted SMS-based interventions in population-based cancer screening programs. METHODS/DESIGN: The M-TICs study is a randomized controlled trial with a formal process evaluation...
2021: PloS One
Divya Bhandari, Akira Shibanuma, Junko Kiriya, Suzita Hirachan, Ken Ing Cherng Ong, Masamine Jimba
BACKGROUND: Breast cancer burden is increasing in low-income countries (LICs). Increasing incidence and delayed presentation of breast cancer are mainly responsible for this burden. Many women do not participate in breast cancer screening despite its effectiveness. Moreover, studies are limited on the barriers associated with low utilization of breast cancer screening in LICs. This study identified breast cancer screening behavior and factors associated with breast cancer screening intention among women in Kathmandu Valley, Nepal...
2021: PloS One
Richard Allman, Erika Spaeth, John Lai, Susan J Gross, John L Hopper
Five-year absolute breast cancer risk prediction models are required to comply with national guidelines regarding risk reduction regimens. Models including the Gail model are under-utilized in the general population for various reasons, including difficulty in accurately completing some clinical fields. The purpose of this study was to determine if a streamlined risk model could be designed without substantial loss in performance. Only the clinical risk factors that were easily answered by women will be retained and combined with an objective validated polygenic risk score (PRS) to ultimately improve overall compliance with professional recommendations...
2021: PloS One
Nadom Safi, Christobel Saunders, Andrew Hayen, Antoinette Anazodo, Kei Lui, Zhuoyang Li, Marc Remond, Michael Nicholl, Alex Y Wang, Elizabeth Sullivan
BACKGROUND: The incidence of gestational breast cancer (GBC) is increasing in high-income countries. Our study aimed to examine the epidemiology, management and outcomes of women with GBC in New South Wales (NSW), Australia. METHODS: A retrospective cohort study using linked data from three NSW datasets. The study group comprised women giving birth with a first-time diagnosis of GBC while the comparison group comprised women giving birth without any type of cancer...
2021: PloS One
Deborah K Johnson, Kaylia M Reynolds, Brian D Poole, Matthew D Montierth, Vera M Todd, April Barnado, Mary F Davis
Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University...
2021: PloS One
(no author information available yet)
Breastfeeding is associated with a decrease in a woman's risk of breast cancer, ovarian cancer, diabetes mellitus, and hypertensive heart disease. Breastfeeding initiation rates in the United States are increasing, and many women are aware of the maternal and infant health benefits of breastfeeding. However, problems may arise that can keep women from achieving their breastfeeding goals, and only 25% of women in the United States are breastfeeding exclusively at 6 months. Many women experience early and undesired weaning because of persistent pain or nipple injury...
February 1, 2021: Obstetrics and Gynecology
(no author information available yet)
Breastfeeding is associated with a decrease in a woman's risk of breast cancer, ovarian cancer, diabetes mellitus, and hypertensive heart disease. Breastfeeding initiation rates in the United States are increasing, and many women are aware of the maternal and infant health benefits of breastfeeding. However, problems may arise that can keep women from achieving their breastfeeding goals, and only 25% of women in the United States are breastfeeding exclusively at 6 months. Many women experience early and undesired weaning because of persistent pain or nipple injury...
February 1, 2021: Obstetrics and Gynecology
Ning O Zhao, Daewoo Pak, Christian El-Hadad, James Matthew Debnam, Jing Ning, Bita Esmaeli
PURPOSE: Retinoblastoma (RB) is the most common intraocular cancer and is associated with lifelong risks of developing a second primary cancer, especially in patients with hereditary RB and/or childhood exposure to radiotherapy. METHODS: The study included all consecutive patients with a history of RB treated for a second primary cancer during 1994-2018. Patient demographics and characteristics of the primary RB and second primary cancer were examined. The associations among radiation or chemotherapy exposure as a treatment for RB, unilateral versus bilateral status, types and multiplicity of second primary cancers, and survival after diagnosis of second primary cancer were analyzed...
January 19, 2021: Asia-Pacific Journal of Ophthalmology
Maria R Valerio, Eugenia Arrivas Bajardi, Carmelo C Arcara, Nicolo' Borsellino, Mario Lo Mauro, Calogero Cipolla, Mariacarmela Santarpia, Alberto Firenze, Gianmarco Motta, Paolo Vigneri, Vittorio Gebbia
OBJECTIVE: Eribulin mesylate (EM) is a fully synthetic macrocyclic ketone analogue of the marine natural product halichondrin. EM has been reported to be active in metastatic breast cancer. In this paper, we report efficacy and safety of data of EM in a retrospective, real-world series of patients with poor prognosis, hormone-refractory, or triple-negative metastatic breast cancer. MATERIALS AND METHODS: The analysis was carried out at 4 interrelated oncology centers...
January 20, 2021: American Journal of Clinical Oncology
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"